鲁北化工(600727.SH):收到控股子公司锦亿科技分红款7650万元
格隆汇3月25日丨鲁北化工(600727.SH)公布,公司控股子公司广西田东锦亿科技有限公司(以下简称“锦亿科技”)2024年度利润分配方案已经锦亿科技股东会审议通过。截止2024年12月31日,锦亿科技可供分配利润5.51亿元,经全体股东表决,一致同意以现金方式向股东分配利润1.5亿元。公司持有锦亿科技51%股权,本次利润分配公司可取得分红款7650万元。
上述分红款项已于2025年3月25日划入公司账户。锦亿科技为公司纳入合并报表范围内的控股子公司,根据相关会计准则,本笔分红款项将增加公司2025年度母公司财务报表利润,对公司2025年度合并财务报表利润不产生影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.